Monday, November 22, 2010 3:45:43 AM
PAION will hold a conference call today, Monday, 22 November 2010 at
10 a.m. CET (9 a.m. GMT, 4 a.m. ET) for media representatives and
shareholders in German. PAION will also be available for analysts and
investors in a further conference call in English at 4 p.m. CET.
PAION will host the conference calls to present details on the headline data of
the Phase IIb study with Remimazolam.
To access the call, please dial:
Germany +49 (0) 69 710445598
UK +44 (0) 20 3003 2666
US + 1 866 966 5335
(other countries: please choose from D/UK/US numbers).
The participant pass code is “PAION”.
To allow for smooth processing we suggest that you dial in ten minutes before
the beginning of the call.
The conference call will be supplemented by a webcast presentation which
can be accessed during the call under the following link:
www.meetingzone.com/presenter/
For the call at 10 a.m. CET, please use the PIN 1961272.
For the call at 4 p.m. CET, please use the PIN 4349347.
The dial-in details for the conference call and the webcast link are also
available on PAION’s website http://www.paion.com
The conference call will be recorded. Details on how to access the replay will
be posted on the same web page after the call.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM